Commentary on “Health economics and the value of therapy in Alzheimer's disease.” Value therapy for Alzheimer's disease—A European perspective-Reference-Cited by-同舟云学术

Commentary on “Health economics and the value of therapy in Alzheimer's disease.” Value therapy for Alzheimer's disease—A European perspective

Published:2007-07 Issue:3 Volume:3 Page:152-156
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Vellas Bruno¹,Froelich Lutz²,Sampaio C.³

Affiliation:

1. Alzheimer's Disease Clinical Research CenterINSERM U 558Department of Internal Medicine and GeriatricsToulouse University Hospital and European Alzheimer's Disease Consortium CenterToulouseFrance

2. Division of Geriatric PsychiatryCentral Institute for Mental HealthUniversity of Heidelberg and European Alzheimer's Disease Consortium CenterMannheimGermany

3. Laboratório de Farmacologia Clínica e Terapêutica e Instituto de Medicina MolecularFaculdade de Medicina de LisboaLisbonPortugal

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2007.04.382

Reference21 articles.

1. The role of pharmacoeconomic modeling in evidence‐based and value‐based formulary guidelines;Malone D.C.;J Manag Care Pharm,2005

2. Realistic expectations for treatment success in Alzheimer's disease;Geldmacher D.S.;J Nutr Health Aging,2006

3. Predictive Value of 6-Month Decline in ADAS-cog for Survival without Severe Alzheimer’s Disease

4. Severe Impairment Battery

5. Efficacy of Donepezil in Early-Stage Alzheimer Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico drug discovery of Acetylcholinesterase and Butyrylcholinesterase enzymes inhibitors based on Quantitative Structure-Activity Relationship (QSAR) and drug-likeness evaluation;Journal of Molecular Structure;2021-04

2. Use of cognitive enhancers and associated medical care costs among patients with dementia: a nationwide study in Taiwan;International Psychogeriatrics;2014-01-16

3. Estudos de QSAR 3D para um conjunto de inibidores de butirilcolinesterase humana;Química Nova;2009